2. UroToday Home
  3. Center Of Excellence
  4. Imaging Center

Imaging Center

Closing Remarks from the 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) - Silke Gillessen, Aurelius Omlin, Neal Shore, Charles Ryan & Alicia Morgans
May 24, 2022
Details
Future Perspectives in Prostate Imaging in Developing Countries - Ronaldo Baroni
May 23, 2022
Details
PSMA PET CT Derived Risk-Stratification Tool for High-risk Prostate Cancer - a UroToday Journal Club - Christopher Wallis & Zachary Klaassen
April 30, 2022
Details
Radiotherapy Guided by PSMA PET Molecular Imaging - Juan Galvis Serrano
April 23, 2022
Details
Higher Rates of Metastatic Disease on PSMA PET for Biochemical Recurrence Risk Groups, Journal Club - Christopher Wallis & Zachary Klaassen
April 14, 2022
Details
Results from the Phase 3 SPOTLIGHT Trial of 18F-rhPSMA-7.3 in Recurrent Prostate Cancer - David Schuster
April 14, 2022
Details
Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne
April 7, 2022
Details
PSMA PET/CT Imaging Indications in Prostate Cancer - Phillip Koo, Neal Shore, & Oliver Sartor
February 11, 2022
Details
NCCN Guidelines On PSMA Molecular Imaging - Tanya Dorff
January 1, 2022
Details
PSMA Imaging - Is Conventional Imaging Obsolete - Steven Rowe
December 26, 2021
Details
Understanding Physiological PSMA Biodistribution - Jeremie Calais
December 6, 2021
Details
Practical Application of 18F-DCFPyL-PET/CT in Patients with Biochemically Recurrent Prostate Cancer: The CONDOR Study - Michael Morris
August 13, 2021
Details
18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer (CONDOR) Journal Club - Christopher Wallis & Zachary Klaassen
June 28, 2021
Details
PYLARIFY®, F 18-labeled PSMA Targeted PET Gains US FDA Approval - Michael Morris
May 28, 2021
Details
The Impact on Patient Care and Clinical Outcomes Gallium 68 PSMA-11 in Suspected Prostate Cancer Metastasis - Jeremie Calais
December 17, 2020
Details
68Ga-PSMA-11 PET approved in Biochemical Recurrent Prostate Cancer - Jeremie Calais
December 8, 2020
Details
68Ga-PSMA-11 Joins FDA-Approved Tools for Management of Prostate Cancer - Thomas Hope
December 7, 2020
Details
Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell
November 3, 2020
Details
CONDOR: Study of 18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer - Michael J. Morris
May 28, 2020
Details
PSMA PET/CT Imaging for Staging High-risk Prostate Cancer Prior to Curative-intent Surgery or Radiotherapy (proPSMA) - Michael Hofman and Declan Murphy
March 23, 2020
Details
PSMA PET Diagnostic Imaging in the Current Era - Jeremie Calais
March 20, 2020
Details
Imaging and Flare Responses When Assessing Patients with Metastatic Castration-Resistant Prostate Cancer - Anwar Padhani
September 26, 2019
Details
Initial Experience with Actinium- 225 PSMA in Advanced Prostate Cancer - Machaba Michael Sathekge
December 29, 2019
Details
Advances in PSMA-directed Radionuclide Therapy - Howard Soule
December 9, 2019
Details
The Use of Novel Imaging Methods in Prostate Cancer - Stefano Fanti
November 18, 2019
Details
Insights on Nuclear Imaging for Prostate Cancer- Stefano Fanti
November 16, 2019
Details
Incorporate Next Generation Imaging Tools Into Clinical Practice - Piet Ost
November 14, 2019
Details
177LU-PSMA-617 in the Treatment of Patients with Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer - Oliver Sartor
October 31, 2019
Details
A Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - The VISION Trial, Interview with Oliver Sartor
October 14, 2019
Details
Advantages of PSMA PET in APC Imaging Presentation - Stefano Fanti
October 2, 2019
Details
PSMA PET CT, A Mixed Blessing - Interview with Ian Davis
October 1, 2019
Details
Gold Nanoparticles Used in Photothermal Therapy for Prostate Tumors- Art Rastinehad
September 23, 2019
Details
Imaging Bone (Flare) Responses in Advanced Prostate Cancer Presentation - Anwar Padhani
September 17, 2019
Details
Credentialing Imaging as an Outcome Measure in Prostate Cancer - Lawrence H. Schwartz and Michael J. Morris
August 15, 2019
Details
SNMMI Osseous Scintigraphy - Ephraim E. Parent
August 14, 2019
Details
Case-based Approaches: PSMA and Personalized Prostate Cancer Care - Frankis Almaguel
August 13, 2019
Details
Bombesin - A New Frontier for Prostate Cancer Imaging - Andrei Iagaru
July 19, 2019
Details
A Study Evaluating Optimal Use of Radioactive Drugs for Prostate Cancer Therapy - Misha Beltran
August 2, 2019
Details
PSMA Theranostics and Personalized Prostate Cancer Care- Frankis Almaguel
July 16, 2019
Details
Focal Therapy - Art Rastinehad
May 26, 2019
Details
Prostate Cancer Diagnosis and Treatment: Incorporating New PET imaging and Theranostic Approaches - Robert Flavell
May 14, 2019
Details
Theranostic Approaches for Advanced Prostate Cancer - Michael Hofman
February 25, 2019
Details
3D Prostate Gland Uptake of 18F Choline PET CT - Association with Overall Survival in Patients with Hormone-naive Prostate Cancer - May Sadik
February 5, 2019
Details
Introducing TIN 117m for Convention Electron Therapy of mCRPC - Suresh Srivastava
January 28, 2019
Details
18F Fluorocholine PET-Whole Body MR in the Staging of High Risk Prostate Cancer - Ur Metser
January 28, 2019
Details
68Ga PSMA 11 PET MRI in Intermediate and High Risk Prostate Cancer - Claudia Zacharias
January 28, 2019
Details
Incremental Value of 11C Acetate Over 68Ga-PSMA PET CT for Prostate Cancer Patients - Sirong Chen
January 21, 2019
Details
Diagnostic Imaging and Therapeutic Aspect of PSMA in Prostate Cancer by Michael Hofman
December 2, 2018
Details
A Review of Imaging Modalities in Prostate Cancer - Peter Pinto
December 2, 2018
Details
PSMA Imaging and Theranostics: Future Impact to Patient Management– Robert Flavell
August 15, 2018
Details
Nuclear Medicine and Lutetium 177 PSMA Therapies - Carmel Pezaro
August 14, 2018
Details
Imaging Modality and Recommendations Included in RADAR 3: Interview with Phillip Koo
June 4, 2018
Details
The Incredible Shrinking nmCRPC - Phillip Koo
May 14, 2018
Details
email news signup